Chemotherapy for ovarian cancer
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (4), 632-635
- https://doi.org/10.1016/s0959-8049(05)80168-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancerBritish Journal of Cancer, 1992
- Neurotoxic side-effects of cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Controlling emesis related to cancer therapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1991
- Medical audit, cancer registration, and survival in ovarian cancerThe Lancet, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989